These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 13506163)

  • 21. [Ion-exchange resins in the elimination of ascites & edema due to hepatic cirrhosis].
    CARNEIRO AS
    Rev Port Med Mil; 1957; 5(1):59-80. PubMed ID: 13506291
    [No Abstract]   [Full Text] [Related]  

  • 22. [Closed extra corporal concentration and reinfusion of ascites in cirrhosis of liver patients with refractory ascites].
    Liu LM; Chi YC; Zhu D; Yang XM; Sun LH
    Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):314. PubMed ID: 15161521
    [No Abstract]   [Full Text] [Related]  

  • 23. Hydrothorax without ascites in liver cirrhosis.
    Pop CM; Gherasim RM; Dumitraşcu DL
    Rom J Gastroenterol; 2003 Dec; 12(4):315-7. PubMed ID: 14726978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of adult patients with ascites due to cirrhosis.
    Runyon BA;
    Hepatology; 2004 Mar; 39(3):841-56. PubMed ID: 14999706
    [No Abstract]   [Full Text] [Related]  

  • 25. New onset ascites secondary to cirrhosis.
    Richert A; Raines D; Lopez FA
    J La State Med Soc; 2009; 161(1):9-13; quiz 13, 54. PubMed ID: 19278163
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cancer antigen 125 as a marker of ascites in patients with liver cirrhosis].
    Jabłkowski M; Białkowska J; Koktysz R; Bartkowiak J; Stankiewicz W; Dworniak D
    Pol Merkur Lekarski; 2004; 17 Suppl 1():149-52. PubMed ID: 15603376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathogenesis of ascites and a consideration of its treatment.
    MADDEN JL; LORE JM; GEROLD FP; RAVID JM
    Surg Gynecol Obstet; 1954 Oct; 99(4):385-91. PubMed ID: 13205408
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic strategies for cirrhosis with ascites recommended by the American Association for Study of Liver Diseases].
    Cui Y; Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):572-3. PubMed ID: 15387924
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of ascites and hepatic hydrothorax.
    Cárdenas A; Arroyo V
    Best Pract Res Clin Gastroenterol; 2007; 21(1):55-75. PubMed ID: 17223497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of hyaluronidase in ascites in cirrhotics].
    GINI RA
    Dia Med; 1953 Oct; 25(69):1923-8. PubMed ID: 13107503
    [No Abstract]   [Full Text] [Related]  

  • 31. Comments on the review article: Ascites in cirrhosis: a review of management and complications.
    Koulaouzidis A; Bhat S
    Neth J Med; 2008 Apr; 66(4):177; author reply 178. PubMed ID: 18424869
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prolonged disappearance of ascites during the evolution of stomach cancer].
    TRAISSAC FJ; DOUTRE LP; FONTANILLE P; MONE P
    Arch Mal Appar Dig Mal Nutr; 1957 Nov; 46(11):1172-7. PubMed ID: 13498898
    [No Abstract]   [Full Text] [Related]  

  • 33. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injection of fibrin glue for temporary treatment of an ascites leak from a ruptured umbilical hernia in a patient with liver cirrhosis.
    Sadik KW; Bonatti H; Schmitt T
    Surgery; 2008 Apr; 143(4):574. PubMed ID: 18374059
    [No Abstract]   [Full Text] [Related]  

  • 35. Ascites and spontaneous bacterial peritonitis: an Asian perspective.
    Lee JM; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1494-503. PubMed ID: 19743995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Octreotide in the treatment of refractory ascites of cirrhosis.
    Leong RW; Jeffrey GP
    Scand J Gastroenterol; 2006 Jun; 41(6):763; author reply 764. PubMed ID: 16716981
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative effect of metacortandracine on diuresis and metabolism of sodium and potassium in normal subjects and during liver cirrhosis].
    BARIETY M; COURY C; GAJDOS A; KOVACEVIC M
    Presse Med (1893); 1956 Oct; 64(75):1699-701. PubMed ID: 13389281
    [No Abstract]   [Full Text] [Related]  

  • 39. Current concepts in the pathogenesis and management of cirrhotic ascites.
    CANTER JW; ROSENTHAL WS; BARONOFSKY ID
    N Y State J Med; 1961 Mar; 61():913-9. PubMed ID: 13690508
    [No Abstract]   [Full Text] [Related]  

  • 40. [Complications of liver cirrhosis: oesophageal varices, ascites and hepato-cellular carcinoma].
    Troillet FX; Halkic N; Froehlich F; Moradpour D; Gonvers JJ; Denys A
    Rev Med Suisse; 2005 Jan; 1(3):249-50, 252-5. PubMed ID: 15770820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.